Compile Data Set for Download or QSAR
Report error Found 76 Enz. Inhib. hit(s) with all data for entry = 13022
TargetComplement factor D(Human)TBA
LigandPNGBDBM752398((S)-2-(2-(11-acetyl-3- methylpyrimido[4',5':6,7] c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752397((S)-2-(2-(11-acetyl-3- methylpyrimido[4',5':6,7] c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752396((2S,4R)-1-(2-(3-acetyl-7- methyl-5-(2-methylpyr- a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752395((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752394((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752385((1R,2S,5S)-3-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752384((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752383((2S,4R)-1-(2-(3-acetyl-7- methyl-5-(2-methylpyrim-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752382((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752380((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752379((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752378((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752393((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752392((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- t...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752391((1R,3S,5R)-2-(2-(11-acet- yl-3-methylpyrimido [4',...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752390((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752389((2S,4R)-1-(2-(3-acetyl-5- (2-methylpyrazolo[1,5-a]...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752388((2S,4R)-1-(2-(3-acetyl-7- methyl-5-(2-methylpyr- a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752387((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752386((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752337((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752336((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752335((1R,3S,5R)-2-(2-(3-acetyl- 5-(2-cyanopyrazolo[1,5-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752334((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752333((2S,4R)-1-(2-(3-acetyl-7- methyl-5-(2-methyl- [1,2...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752332((2S,4R)-1-(2-(3-acetyl-7- methyl-5-(2-methylpyr- a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752331((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752345((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752344((1R,3S,5R)-2-(2-(3-acetyl- 5-(2-cyano-[1,2,4]triaz...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752343((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752342((1R,3S,5R)-2-(2-(8'-acetyl- 1'H-spiro[oxetane-3,2'...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752341((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752340((1R,3S,5R)-2-(2-(3-acetyl- 5-(2-((R)-1-hydroxyethy...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752339((1R,3S,5R)-2-(2-(3-acetyl- 5-(2-((S)-1-hydroxyethy...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752338((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752329((1R,2S,5S)-3-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752328((1R,2S,5S)-3-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752327((1R,3S,5R)-2-(2-(3-acetyl- 6-fluoro-7-methyl-5-(2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752326((1R,2S,5S)-3-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752304((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752299((1R,3S,5R)-2-(2-(3-acetyl- 6-fluoro-7-methyl-5-(2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752290((1R,2S,5S)-3-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752369((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752368((1R,3S,5R)-2-(2-(3-acetyl- 7-(fluoromethyl)-5-(2- ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752367((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752366((1R,3S,5R)-2-(2-(3-acetyl- 6-fluoro-7-methyl-5-(2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752365((1R,3S,5R)-2-(2-(3-acetyl- 7-(hydroxymethyl)-5-(2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752364((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752363((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

TargetComplement factor D(Human)TBA
LigandPNGBDBM752362((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-5-(2-methyl- [...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: